Skip to main content

Table 2 Demographic and disease-related characteristics at baseline

From: Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study

 AllEWGSOPEWGSOP2FNIH
No sarcopenia n = 227 (79%)Sarcopenia n = 60 (21%)Not probable sarcopenia
n = 78 (27%)
Probable sarcopenia
n = 209 (73%)
No sarcopenia
N = 229 (80%)
Sarcopenia
N = 58 (20%)
No sarcopenia
N = 261 (92%)
Sarcopenia N = 24 (8%)
Age, years, mean (SD)86.6 (1.0)86.6 (1.0)86.6 (1.0)86.3 (0.9)86.7 (1.1)***86.6 (1.1)86.5 (1.0)86.6 (1.0)86.6 (1.1)
Education, n (%)
 6–7 years140 (49)113 (50)27 (45)33 (42)107 (51)112 (49)28 (48)123 (47)16 (67)
 8–13 years88 (31)65 (29)23 (38)27 (35)61 (29)67 (29)21 (36)81 (31)7 (29)
 > 13 years59 (20)49 (21)10 (17)18 (23)41 (20)50 (22)9 (16)57 (22)1 (4)
MMSE score, median (IQR)28 (3)28 (3)28 (3)28 (2)28 (3)28 (3)28 (3)28 (2)26.5 (4.5)
Charlson score, median (IQR)1 (2)1 (2)1 (2)1 (1)1 (2)*1 (2)1 (2)1 (2)1.5 (2)**
Myocardial infarction, n (%)57 (20)41 (18)16 (27)17 (22)40 (19)44 (19)13 (22)47 (18)10 (42)*
Heart failure, n (%)38 (13)30 (13)8 (13)7 (9)31 (15)34 (15)4 (7)32 (12)6 (25)
Peripheral vascular disease, n (%)11 (4)9 (4)2 (3)4 (5)7 (3)10 (4)1 (2)9 (3)2 (8)
Cerebrovascular disease, n (%)41 (14)32 (14)9 (15)9 (12)32 (15)30 (13)11 (19)38 (15)3 (13)
Dementia, n (%)4 (1)4 (2)0 (0)2 (3)2 (1)4 (2)0 (0)4 (2)0 (0)
Chronic pulmonary disease, n (%)17 (6)13 (6)4 (7)3 (4)14 (7)12 (5)5 (9)14 (5)2 (8)
Rheumatic disease, n (%)12 (4)9 (4)3 (5)0 (0)12 (6)*9 (4)3 (5)8 (3)3 (13)
Diabetes, n (%)27 (9)17 (7)10 (17)*5 (6)22 (11)21 (9)6 (10)19 (7)8 (33)**
Renal disease, n (%)8 (3)6 (3)2 (3)2 (3)6 (3)5 (2)3 (5)7 (3)1 (4)
History of cancer, n (%)56 (20)48 (21)8 (13)8 (10)48 (23)*46 (20)10 (17)50 (19)6 (25)
Smoking 
 yes, n (%)16 (6)12 (5)4 (7)4 (5)12 (6)14 (6)2 (3)14 (5)2 (8)
 no, n (%)271 (94)215 (95)56 (93)74 (95)197 (94)215 (94)56 (97)247 (95)22 (92)
  1. *p < 0.05; **p < 0.01; ***p < 0.001
  2. EWGSOP European Working Group on Sarcopenia in Older People [3], EWGSOP2 European Working Group on Sarcopenia in Older People, 2018 update [4], FNIH Foundation for the National Institutes of Health Sarcopenia Project [9], MMSE mini mental state exam, Charlson Charlson comorbidity index
\